nodes	percent_of_prediction	percent_of_DWPC	metapath
Alpha-Linolenic Acid—FABP7—breast cancer	0.704	1	CbGaD
Alpha-Linolenic Acid—FABP3—mammary gland—breast cancer	0.006	0.0629	CbGeAlD
Alpha-Linolenic Acid—FADS2—mammary gland—breast cancer	0.00455	0.0476	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—nipple—breast cancer	0.00442	0.0463	CbGeAlD
Alpha-Linolenic Acid—FABP7—mammary gland—breast cancer	0.00393	0.0412	CbGeAlD
Alpha-Linolenic Acid—FADS2—nipple—breast cancer	0.00376	0.0394	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—embryo—breast cancer	0.00365	0.0382	CbGeAlD
Alpha-Linolenic Acid—FADS1—nipple—breast cancer	0.00295	0.0309	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—skin of body—breast cancer	0.00283	0.0297	CbGeAlD
Alpha-Linolenic Acid—FABP3—adipose tissue—breast cancer	0.0027	0.0283	CbGeAlD
Alpha-Linolenic Acid—FABP7—embryo—breast cancer	0.00268	0.0281	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—endometrium—breast cancer	0.00267	0.028	CbGeAlD
Alpha-Linolenic Acid—Dihomo-gamma-linolenic acid—FABP7—breast cancer	0.00267	0.453	CrCbGaD
Alpha-Linolenic Acid—FADS2—epithelium—breast cancer	0.00253	0.0265	CbGeAlD
Alpha-Linolenic Acid—FABP3—female reproductive system—breast cancer	0.00248	0.026	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—pituitary gland—breast cancer	0.00242	0.0253	CbGeAlD
Alpha-Linolenic Acid—FADS2—skin of body—breast cancer	0.00241	0.0252	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—adipose tissue—breast cancer	0.00241	0.0252	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—female reproductive system—breast cancer	0.00221	0.0232	CbGeAlD
Alpha-Linolenic Acid—FABP3—endocrine gland—breast cancer	0.0021	0.022	CbGeAlD
Alpha-Linolenic Acid—Icosapent—FABP7—breast cancer	0.00209	0.355	CrCbGaD
Alpha-Linolenic Acid—FADS2—uterus—breast cancer	0.00209	0.0219	CbGeAlD
Alpha-Linolenic Acid—FADS2—pituitary gland—breast cancer	0.00206	0.0215	CbGeAlD
Alpha-Linolenic Acid—FADS2—adipose tissue—breast cancer	0.00205	0.0214	CbGeAlD
Alpha-Linolenic Acid—TRPV1—epithelium—breast cancer	0.00199	0.0208	CbGeAlD
Alpha-Linolenic Acid—FADS2—female reproductive system—breast cancer	0.00188	0.0197	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—endocrine gland—breast cancer	0.00187	0.0196	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—endocrine gland—breast cancer	0.00187	0.0196	CbGeAlD
Alpha-Linolenic Acid—FADS2—adrenal gland—breast cancer	0.00184	0.0192	CbGeAlD
Alpha-Linolenic Acid—FADS1—endometrium—breast cancer	0.00178	0.0187	CbGeAlD
Alpha-Linolenic Acid—FADS2—female gonad—breast cancer	0.00171	0.0179	CbGeAlD
Alpha-Linolenic Acid—FADS1—uterus—breast cancer	0.00164	0.0172	CbGeAlD
Alpha-Linolenic Acid—FABP7—female reproductive system—breast cancer	0.00163	0.017	CbGeAlD
Alpha-Linolenic Acid—FADS1—pituitary gland—breast cancer	0.00161	0.0169	CbGeAlD
Alpha-Linolenic Acid—FADS1—adipose tissue—breast cancer	0.00161	0.0168	CbGeAlD
Alpha-Linolenic Acid—FADS2—endocrine gland—breast cancer	0.00159	0.0167	CbGeAlD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Lapatinib—breast cancer	0.00153	0.0187	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—female reproductive system—breast cancer	0.00148	0.0155	CbGeAlD
Alpha-Linolenic Acid—FADS1—adrenal gland—breast cancer	0.00144	0.0151	CbGeAlD
Alpha-Linolenic Acid—FADS1—bone marrow—breast cancer	0.00139	0.0146	CbGeAlD
Alpha-Linolenic Acid—FABP7—endocrine gland—breast cancer	0.00138	0.0144	CbGeAlD
Alpha-Linolenic Acid—FADS1—female gonad—breast cancer	0.00134	0.0141	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—lymph node—breast cancer	0.00129	0.0136	CbGeAlD
Alpha-Linolenic Acid—TRPV1—endocrine gland—breast cancer	0.00125	0.0131	CbGeAlD
Alpha-Linolenic Acid—Anaphylactic shock—Fluoxymesterone—breast cancer	0.0012	0.0147	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Anastrozole—breast cancer	0.00111	0.0135	CcSEcCtD
Alpha-Linolenic Acid—FADS2—lymph node—breast cancer	0.0011	0.0115	CbGeAlD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Anastrozole—breast cancer	0.00108	0.0133	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Raloxifene—breast cancer	0.00105	0.0128	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Lapatinib—breast cancer	0.00104	0.0128	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Fulvestrant—breast cancer	0.000958	0.0117	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Toremifene—breast cancer	0.000945	0.0116	CcSEcCtD
Alpha-Linolenic Acid—FADS1—lymph node—breast cancer	0.000864	0.00905	CbGeAlD
Alpha-Linolenic Acid—Anaphylactic shock—Lapatinib—breast cancer	0.00085	0.0104	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Ixabepilone—breast cancer	0.000785	0.00961	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Tamoxifen—breast cancer	0.000756	0.00926	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Lapatinib—breast cancer	0.000748	0.00916	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Tamoxifen—breast cancer	0.000741	0.00907	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Letrozole—breast cancer	0.000739	0.00905	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Lapatinib—breast cancer	0.000734	0.00899	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Lapatinib—breast cancer	0.000727	0.0089	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Anastrozole—breast cancer	0.000724	0.00886	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Letrozole—breast cancer	0.000724	0.00886	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Idarubicin—breast cancer	0.000702	0.00859	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Fulvestrant—breast cancer	0.000688	0.00843	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Fulvestrant—breast cancer	0.000675	0.00826	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Fulvestrant—breast cancer	0.000669	0.00819	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Toremifene—breast cancer	0.000666	0.00816	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Toremifene—breast cancer	0.00066	0.00808	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Vinorelbine—breast cancer	0.000647	0.00792	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Thiotepa—breast cancer	0.000618	0.00757	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Thiotepa—breast cancer	0.000605	0.00741	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Anastrozole—breast cancer	0.000603	0.00739	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Letrozole—breast cancer	0.000603	0.00739	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Lapatinib—breast cancer	0.000601	0.00736	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Exemestane—breast cancer	0.000598	0.00732	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Exemestane—breast cancer	0.000586	0.00718	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Exemestane—breast cancer	0.000581	0.00711	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Idarubicin—breast cancer	0.000573	0.00701	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Ixabepilone—breast cancer	0.000553	0.00677	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Fulvestrant—breast cancer	0.000553	0.00677	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Ixabepilone—breast cancer	0.000548	0.00671	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Toremifene—breast cancer	0.000546	0.00668	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Lapatinib—breast cancer	0.00054	0.00662	CcSEcCtD
Alpha-Linolenic Acid—Rash—Lapatinib—breast cancer	0.000536	0.00656	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Lapatinib—breast cancer	0.000535	0.00656	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Mitoxantrone—breast cancer	0.000534	0.00654	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Irinotecan—breast cancer	0.000534	0.00654	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Letrozole—breast cancer	0.000531	0.0065	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Anastrozole—breast cancer	0.000531	0.0065	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Mitoxantrone—breast cancer	0.000523	0.0064	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Letrozole—breast cancer	0.000521	0.00638	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Anastrozole—breast cancer	0.000521	0.00638	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Gemcitabine—breast cancer	0.00052	0.00637	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Anastrozole—breast cancer	0.000516	0.00632	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Letrozole—breast cancer	0.000516	0.00632	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Gemcitabine—breast cancer	0.000509	0.00623	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Raloxifene—breast cancer	0.000504	0.00617	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Fulvestrant—breast cancer	0.000497	0.00609	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Tamoxifen—breast cancer	0.000495	0.00607	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Raloxifene—breast cancer	0.000494	0.00605	CcSEcCtD
Alpha-Linolenic Acid—Rash—Fulvestrant—breast cancer	0.000493	0.00604	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Fulvestrant—breast cancer	0.000492	0.00603	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Toremifene—breast cancer	0.000491	0.00601	CcSEcCtD
Alpha-Linolenic Acid—Rash—Toremifene—breast cancer	0.000487	0.00596	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Toremifene—breast cancer	0.000486	0.00595	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Goserelin—breast cancer	0.000483	0.00592	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Exemestane—breast cancer	0.00048	0.00588	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Ixabepilone—breast cancer	0.000453	0.00555	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Paclitaxel—breast cancer	0.000435	0.00533	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Vinorelbine—breast cancer	0.000433	0.0053	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Exemestane—breast cancer	0.000432	0.00529	CcSEcCtD
Alpha-Linolenic Acid—Rash—Exemestane—breast cancer	0.000428	0.00524	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Exemestane—breast cancer	0.000428	0.00524	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Letrozole—breast cancer	0.000427	0.00523	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Anastrozole—breast cancer	0.000427	0.00523	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Paclitaxel—breast cancer	0.000426	0.00522	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Thiotepa—breast cancer	0.000413	0.00506	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Chlorambucil—breast cancer	0.000408	0.005	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Ixabepilone—breast cancer	0.000407	0.00499	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Melphalan—breast cancer	0.000404	0.00495	CcSEcCtD
Alpha-Linolenic Acid—Dihomo-gamma-linolenic acid—PTGS1—breast cancer	0.000404	0.0686	CrCbGaD
Alpha-Linolenic Acid—Rash—Ixabepilone—breast cancer	0.000404	0.00495	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Ixabepilone—breast cancer	0.000404	0.00494	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Chlorambucil—breast cancer	0.0004	0.0049	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Goserelin—breast cancer	0.000394	0.00483	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Letrozole—breast cancer	0.000384	0.0047	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Anastrozole—breast cancer	0.000384	0.0047	CcSEcCtD
Alpha-Linolenic Acid—Rash—Anastrozole—breast cancer	0.00038	0.00466	CcSEcCtD
Alpha-Linolenic Acid—Rash—Letrozole—breast cancer	0.00038	0.00466	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Anastrozole—breast cancer	0.00038	0.00465	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Letrozole—breast cancer	0.00038	0.00465	CcSEcCtD
Alpha-Linolenic Acid—Eructation—Epirubicin—breast cancer	0.000374	0.00458	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Docetaxel—breast cancer	0.000369	0.00452	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Raloxifene—breast cancer	0.000364	0.00446	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Idarubicin—breast cancer	0.000364	0.00446	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Vinblastine—breast cancer	0.000363	0.00445	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Tamoxifen—breast cancer	0.000363	0.00445	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Docetaxel—breast cancer	0.000361	0.00442	CcSEcCtD
Alpha-Linolenic Acid—Rash—Raloxifene—breast cancer	0.000361	0.00442	CcSEcCtD
Alpha-Linolenic Acid—Rash—Idarubicin—breast cancer	0.000361	0.00442	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Raloxifene—breast cancer	0.000361	0.00442	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Idarubicin—breast cancer	0.000361	0.00442	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Capecitabine—breast cancer	0.000357	0.00437	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Tamoxifen—breast cancer	0.000356	0.00436	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Melphalan—breast cancer	0.000356	0.00436	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Vinorelbine—breast cancer	0.000353	0.00432	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Tamoxifen—breast cancer	0.000353	0.00432	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Capecitabine—breast cancer	0.00035	0.00428	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Mitoxantrone—breast cancer	0.00035	0.00428	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Melphalan—breast cancer	0.000349	0.00427	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Goserelin—breast cancer	0.000347	0.00425	CcSEcCtD
Alpha-Linolenic Acid—Eructation—Doxorubicin—breast cancer	0.000346	0.00424	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Goserelin—breast cancer	0.000337	0.00413	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Chlorambucil—breast cancer	0.000328	0.00402	CcSEcCtD
Alpha-Linolenic Acid—Icosapent—PTGS1—breast cancer	0.000317	0.0538	CrCbGaD
Alpha-Linolenic Acid—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000305	0.00373	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Vinorelbine—breast cancer	0.000302	0.0037	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Thiotepa—breast cancer	0.000297	0.00364	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Chlorambucil—breast cancer	0.000295	0.00361	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Tamoxifen—breast cancer	0.000292	0.00358	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Irinotecan—breast cancer	0.000291	0.00357	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Mitoxantrone—breast cancer	0.000291	0.00357	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Thiotepa—breast cancer	0.000291	0.00357	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Paclitaxel—breast cancer	0.000291	0.00356	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Thiotepa—breast cancer	0.000288	0.00353	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Melphalan—breast cancer	0.000286	0.0035	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Paclitaxel—breast cancer	0.000285	0.00349	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Gemcitabine—breast cancer	0.000284	0.00347	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Goserelin—breast cancer	0.000279	0.00342	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Fluorouracil—breast cancer	0.000279	0.00342	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Vinblastine—breast cancer	0.00027	0.00331	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Tamoxifen—breast cancer	0.000263	0.00321	CcSEcCtD
Alpha-Linolenic Acid—Rash—Tamoxifen—breast cancer	0.00026	0.00319	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Tamoxifen—breast cancer	0.00026	0.00318	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Melphalan—breast cancer	0.000257	0.00315	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Irinotecan—breast cancer	0.000256	0.00314	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Mitoxantrone—breast cancer	0.000256	0.00314	CcSEcCtD
Alpha-Linolenic Acid—Rash—Melphalan—breast cancer	0.000255	0.00312	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Melphalan—breast cancer	0.000255	0.00312	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Irinotecan—breast cancer	0.000251	0.00308	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Goserelin—breast cancer	0.000251	0.00307	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Vinorelbine—breast cancer	0.00025	0.00306	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Irinotecan—breast cancer	0.000249	0.00305	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Mitoxantrone—breast cancer	0.000249	0.00305	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Epirubicin—breast cancer	0.000249	0.00305	CcSEcCtD
Alpha-Linolenic Acid—Rash—Goserelin—breast cancer	0.000249	0.00304	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Goserelin—breast cancer	0.000248	0.00304	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Docetaxel—breast cancer	0.000247	0.00302	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Fluorouracil—breast cancer	0.000246	0.00301	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000245	0.003	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Epirubicin—breast cancer	0.000244	0.00298	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Gemcitabine—breast cancer	0.000243	0.00297	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Docetaxel—breast cancer	0.000242	0.00296	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000241	0.00295	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Capecitabine—breast cancer	0.000239	0.00293	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Thiotepa—breast cancer	0.000239	0.00292	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Paclitaxel—breast cancer	0.000238	0.00291	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Capecitabine—breast cancer	0.000234	0.00286	CcSEcCtD
Alpha-Linolenic Acid—Dihomo-gamma-linolenic acid—PTGS2—breast cancer	0.000231	0.0392	CrCbGaD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Doxorubicin—breast cancer	0.00023	0.00282	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Doxorubicin—breast cancer	0.000226	0.00276	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Vinorelbine—breast cancer	0.000225	0.00275	CcSEcCtD
Alpha-Linolenic Acid—Rash—Vinorelbine—breast cancer	0.000223	0.00273	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Vinorelbine—breast cancer	0.000222	0.00272	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Thiotepa—breast cancer	0.000214	0.00263	CcSEcCtD
Alpha-Linolenic Acid—Rash—Thiotepa—breast cancer	0.000213	0.0026	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Thiotepa—breast cancer	0.000212	0.0026	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Paclitaxel—breast cancer	0.000209	0.00256	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000205	0.00251	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Paclitaxel—breast cancer	0.000203	0.00249	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Docetaxel—breast cancer	0.000201	0.00247	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Gemcitabine—breast cancer	0.000201	0.00246	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Fluorouracil—breast cancer	0.000197	0.00242	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Mitoxantrone—breast cancer	0.000185	0.00227	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Irinotecan—breast cancer	0.000185	0.00227	CcSEcCtD
Alpha-Linolenic Acid—Rash—Mitoxantrone—breast cancer	0.000184	0.00225	CcSEcCtD
Alpha-Linolenic Acid—Rash—Irinotecan—breast cancer	0.000184	0.00225	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Irinotecan—breast cancer	0.000183	0.00225	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Mitoxantrone—breast cancer	0.000183	0.00225	CcSEcCtD
Alpha-Linolenic Acid—Icosapent—PTGS2—breast cancer	0.000181	0.0308	CrCbGaD
Alpha-Linolenic Acid—Vomiting—Gemcitabine—breast cancer	0.00018	0.00221	CcSEcCtD
Alpha-Linolenic Acid—Rash—Gemcitabine—breast cancer	0.000179	0.00219	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Gemcitabine—breast cancer	0.000179	0.00219	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Methotrexate—breast cancer	0.000178	0.00218	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Fluorouracil—breast cancer	0.000177	0.00217	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Docetaxel—breast cancer	0.000177	0.00217	CcSEcCtD
Alpha-Linolenic Acid—Rash—Fluorouracil—breast cancer	0.000176	0.00215	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Fluorouracil—breast cancer	0.000176	0.00215	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Methotrexate—breast cancer	0.000174	0.00213	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Docetaxel—breast cancer	0.000174	0.00213	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Docetaxel—breast cancer	0.000172	0.00211	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Capecitabine—breast cancer	0.000172	0.0021	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Capecitabine—breast cancer	0.000168	0.00206	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Paclitaxel—breast cancer	0.000168	0.00206	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Capecitabine—breast cancer	0.000167	0.00204	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Epirubicin—breast cancer	0.000166	0.00204	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Epirubicin—breast cancer	0.000163	0.002	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Doxorubicin—breast cancer	0.000154	0.00189	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Paclitaxel—breast cancer	0.000151	0.00185	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Doxorubicin—breast cancer	0.000151	0.00185	CcSEcCtD
Alpha-Linolenic Acid—Rash—Paclitaxel—breast cancer	0.00015	0.00183	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Paclitaxel—breast cancer	0.00015	0.00183	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Methotrexate—breast cancer	0.000145	0.00178	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Docetaxel—breast cancer	0.000142	0.00174	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Capecitabine—breast cancer	0.000138	0.00169	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Epirubicin—breast cancer	0.000136	0.00166	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Docetaxel—breast cancer	0.000128	0.00157	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Methotrexate—breast cancer	0.000128	0.00156	CcSEcCtD
Alpha-Linolenic Acid—Rash—Docetaxel—breast cancer	0.000127	0.00155	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Docetaxel—breast cancer	0.000127	0.00155	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Doxorubicin—breast cancer	0.000126	0.00154	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Methotrexate—breast cancer	0.000125	0.00153	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Capecitabine—breast cancer	0.000124	0.00152	CcSEcCtD
Alpha-Linolenic Acid—Rash—Capecitabine—breast cancer	0.000123	0.00151	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Capecitabine—breast cancer	0.000123	0.0015	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Epirubicin—breast cancer	0.00012	0.00146	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Epirubicin—breast cancer	0.000117	0.00144	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Epirubicin—breast cancer	0.000116	0.00142	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Doxorubicin—breast cancer	0.000111	0.00135	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000108	0.00133	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Doxorubicin—breast cancer	0.000107	0.00132	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Methotrexate—breast cancer	0.000103	0.00126	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Epirubicin—breast cancer	9.61e-05	0.00118	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—ALDH7A1—breast cancer	9.45e-05	0.000834	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IFNB1—breast cancer	9.43e-05	0.000832	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—HBA1—breast cancer	9.39e-05	0.000829	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	9.34e-05	0.000824	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—TFRC—breast cancer	9.27e-05	0.000818	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Methotrexate—breast cancer	9.23e-05	0.00113	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTT1—breast cancer	9.16e-05	0.000809	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ACHE—breast cancer	9.16e-05	0.000809	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Methotrexate—breast cancer	9.15e-05	0.00112	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Methotrexate—breast cancer	9.14e-05	0.00112	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—UMPS—breast cancer	9.06e-05	0.000799	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ADSL—breast cancer	9.06e-05	0.000799	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PHGDH—breast cancer	9.06e-05	0.000799	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NME1—breast cancer	9.06e-05	0.000799	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—FHL2—breast cancer	9.06e-05	0.000799	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—TFRC—breast cancer	8.95e-05	0.00079	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—NCOA2—breast cancer	8.92e-05	0.000788	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Doxorubicin—breast cancer	8.89e-05	0.00109	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—HPSE—breast cancer	8.88e-05	0.000784	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—BRIP1—breast cancer	8.88e-05	0.000784	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—LDHB—breast cancer	8.88e-05	0.000784	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP17A1—breast cancer	8.67e-05	0.000766	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PLAUR—breast cancer	8.66e-05	0.000764	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Epirubicin—breast cancer	8.64e-05	0.00106	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—NCOA2—breast cancer	8.62e-05	0.000761	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PTGS1—breast cancer	8.59e-05	0.000758	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ENO1—breast cancer	8.59e-05	0.000758	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Epirubicin—breast cancer	8.56e-05	0.00105	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Epirubicin—breast cancer	8.56e-05	0.00105	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.55e-05	0.000755	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.54e-05	0.000754	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.51e-05	0.000751	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PLG—breast cancer	8.46e-05	0.000747	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.44e-05	0.000745	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP2D6—breast cancer	8.42e-05	0.000743	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTA3—breast cancer	8.42e-05	0.000743	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HMMR—breast cancer	8.42e-05	0.000743	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ABCC1—breast cancer	8.42e-05	0.000743	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—DPYD—breast cancer	8.28e-05	0.000731	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—MED12—breast cancer	8.28e-05	0.000731	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NCOA2—breast cancer	8.26e-05	0.00073	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.22e-05	0.000726	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	8.22e-05	0.000726	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ALDOA—breast cancer	8.15e-05	0.00072	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PPARGC1B—breast cancer	8.15e-05	0.00072	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PDGFA—breast cancer	8.04e-05	0.000709	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—FASN—breast cancer	8.02e-05	0.000708	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Doxorubicin—breast cancer	7.99e-05	0.000978	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—SLC-mediated transmembrane transport—ALB—breast cancer	7.99e-05	0.000705	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—BCHE—breast cancer	7.98e-05	0.000705	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	7.94e-05	0.000701	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	7.94e-05	0.000701	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.94e-05	0.000701	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Doxorubicin—breast cancer	7.92e-05	0.00097	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Doxorubicin—breast cancer	7.92e-05	0.000969	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOA3—breast cancer	7.92e-05	0.000699	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—SLC5A5—breast cancer	7.88e-05	0.000696	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SLC2A2—breast cancer	7.86e-05	0.000694	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ITPR1—breast cancer	7.79e-05	0.000688	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.78e-05	0.000687	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ABL1—breast cancer	7.74e-05	0.000683	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CPT1A—breast cancer	7.7e-05	0.00068	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—MTR—breast cancer	7.7e-05	0.00068	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CA9—breast cancer	7.7e-05	0.00068	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ABCG2—breast cancer	7.7e-05	0.00068	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTA4—breast cancer	7.7e-05	0.00068	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NQO1—breast cancer	7.61e-05	0.000672	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—SLC2A1—breast cancer	7.61e-05	0.000672	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	7.6e-05	0.000671	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—HPGDS—breast cancer	7.55e-05	0.000667	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	7.53e-05	0.000664	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—NCOA1—breast cancer	7.52e-05	0.000664	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—HBA1—breast cancer	7.5e-05	0.000662	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTA2—breast cancer	7.5e-05	0.000662	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GPX2—breast cancer	7.5e-05	0.000662	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.46e-05	0.000658	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP3A4—breast cancer	7.43e-05	0.000655	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SULT1A1—breast cancer	7.41e-05	0.000654	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GPX4—breast cancer	7.41e-05	0.000654	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.39e-05	0.000652	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—PLG—breast cancer	7.33e-05	0.000647	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTT1—breast cancer	7.32e-05	0.000647	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ACHE—breast cancer	7.32e-05	0.000647	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP1B1—breast cancer	7.3e-05	0.000644	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PLA2G4A—breast cancer	7.28e-05	0.000643	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—HGF—breast cancer	7.28e-05	0.000643	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—NCOA1—breast cancer	7.26e-05	0.000641	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTA1—breast cancer	7.24e-05	0.000639	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—IDH1—breast cancer	7.24e-05	0.000639	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CSF2—breast cancer	7.2e-05	0.000635	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—HSP90AA1—breast cancer	7.16e-05	0.000632	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NAT2—breast cancer	7.16e-05	0.000632	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—PLG—breast cancer	7.08e-05	0.000625	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NCOA1—breast cancer	6.96e-05	0.000615	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP17A1—breast cancer	6.93e-05	0.000612	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PTGS1—breast cancer	6.86e-05	0.000606	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—STK11—breast cancer	6.86e-05	0.000606	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP19A1—breast cancer	6.86e-05	0.000606	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ENO1—breast cancer	6.86e-05	0.000606	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.84e-05	0.000604	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—HMOX1—breast cancer	6.76e-05	0.000597	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.75e-05	0.000596	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP2D6—breast cancer	6.73e-05	0.000594	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOA2—breast cancer	6.61e-05	0.000583	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—HMOX1—breast cancer	6.53e-05	0.000576	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—ABCB1—breast cancer	6.49e-05	0.000573	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	6.47e-05	0.000571	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.44e-05	0.000569	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—FASN—breast cancer	6.41e-05	0.000566	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—BCHE—breast cancer	6.38e-05	0.000563	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—COMT—breast cancer	6.38e-05	0.000563	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTP1—breast cancer	6.35e-05	0.000561	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SLC5A5—breast cancer	6.3e-05	0.000556	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—DPYD—breast cancer	6.28e-05	0.000554	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—MED12—breast cancer	6.28e-05	0.000554	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—ABCB1—breast cancer	6.27e-05	0.000553	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—HMOX1—breast cancer	6.26e-05	0.000553	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ITPR1—breast cancer	6.25e-05	0.000552	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—MMP1—breast cancer	6.19e-05	0.000546	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ALDOA—breast cancer	6.18e-05	0.000546	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SLC2A1—breast cancer	6.09e-05	0.000537	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NQO1—breast cancer	6.09e-05	0.000537	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CDK2—breast cancer	6.07e-05	0.000536	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PLAU—breast cancer	6.07e-05	0.000536	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ABCB1—breast cancer	6.01e-05	0.000531	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOA3—breast cancer	6e-05	0.00053	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.96e-05	0.000526	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SLC2A2—breast cancer	5.96e-05	0.000526	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP3A4—breast cancer	5.94e-05	0.000524	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CAV1—breast cancer	5.93e-05	0.000524	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.91e-05	0.000521	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—TYMS—breast cancer	5.9e-05	0.000521	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.9e-05	0.00052	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP1B1—breast cancer	5.84e-05	0.000515	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PLA2G4A—breast cancer	5.84e-05	0.000515	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NCOR1—breast cancer	5.84e-05	0.000515	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—MTR—breast cancer	5.84e-05	0.000515	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTM1—breast cancer	5.84e-05	0.000515	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CPT1A—breast cancer	5.84e-05	0.000515	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ABCG2—breast cancer	5.84e-05	0.000515	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL6—breast cancer	5.76e-05	0.000508	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HPGDS—breast cancer	5.72e-05	0.000505	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—HSP90AA1—breast cancer	5.72e-05	0.000505	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HBA1—breast cancer	5.69e-05	0.000502	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—FN1—breast cancer	5.65e-05	0.000499	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GPX1—breast cancer	5.59e-05	0.000493	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—NOS2—breast cancer	5.58e-05	0.000493	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOA1—breast cancer	5.57e-05	0.000491	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTT1—breast cancer	5.55e-05	0.00049	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ACHE—breast cancer	5.55e-05	0.00049	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP1A1—breast cancer	5.53e-05	0.000488	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ERCC2—breast cancer	5.49e-05	0.000484	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—STK11—breast cancer	5.49e-05	0.000484	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP19A1—breast cancer	5.49e-05	0.000484	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CG—breast cancer	5.4e-05	0.000477	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—EGF—breast cancer	5.34e-05	0.000472	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP17A1—breast cancer	5.25e-05	0.000464	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PTGS1—breast cancer	5.2e-05	0.000459	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ENO1—breast cancer	5.2e-05	0.000459	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.18e-05	0.000457	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—MTHFR—breast cancer	5.16e-05	0.000455	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.15e-05	0.000455	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.12e-05	0.000452	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP2D6—breast cancer	5.1e-05	0.00045	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—COMT—breast cancer	5.1e-05	0.00045	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTP1—breast cancer	5.08e-05	0.000448	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—HMOX1—breast cancer	5.01e-05	0.000442	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOA2—breast cancer	5.01e-05	0.000442	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ITPR1—breast cancer	5e-05	0.000441	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IGF1—breast cancer	4.95e-05	0.000437	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—AKT2—breast cancer	4.94e-05	0.000437	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—FASN—breast cancer	4.86e-05	0.000429	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—BCHE—breast cancer	4.84e-05	0.000427	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ABCB1—breast cancer	4.81e-05	0.000424	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SLC5A5—breast cancer	4.78e-05	0.000422	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CAV1—breast cancer	4.76e-05	0.00042	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CD—breast cancer	4.75e-05	0.000419	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—TYMS—breast cancer	4.72e-05	0.000417	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SERPINE1—breast cancer	4.7e-05	0.000415	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ALB—breast cancer	4.69e-05	0.000414	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PLA2G4A—breast cancer	4.67e-05	0.000412	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTM1—breast cancer	4.67e-05	0.000412	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOR1—breast cancer	4.67e-05	0.000412	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SLC2A1—breast cancer	4.61e-05	0.000407	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NQO1—breast cancer	4.61e-05	0.000407	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.55e-05	0.000401	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.52e-05	0.000399	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP3A4—breast cancer	4.5e-05	0.000397	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—NOS3—breast cancer	4.49e-05	0.000396	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.48e-05	0.000395	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GPX1—breast cancer	4.47e-05	0.000394	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP1A1—breast cancer	4.42e-05	0.00039	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP1B1—breast cancer	4.42e-05	0.00039	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ERCC2—breast cancer	4.39e-05	0.000387	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HSP90AA1—breast cancer	4.34e-05	0.000383	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CG—breast cancer	4.33e-05	0.000383	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—RAF1—breast cancer	4.24e-05	0.000374	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOA1—breast cancer	4.22e-05	0.000372	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—STK11—breast cancer	4.16e-05	0.000367	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP19A1—breast cancer	4.16e-05	0.000367	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CB—breast cancer	4.14e-05	0.000366	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—MTHFR—breast cancer	4.12e-05	0.000364	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—ALB—breast cancer	4.06e-05	0.000358	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—ALB—breast cancer	3.92e-05	0.000346	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.9e-05	0.000345	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—COMT—breast cancer	3.87e-05	0.000341	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTP1—breast cancer	3.85e-05	0.00034	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CD—breast cancer	3.81e-05	0.000336	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CAV1—breast cancer	3.8e-05	0.000336	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IL2—breast cancer	3.8e-05	0.000336	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HMOX1—breast cancer	3.79e-05	0.000335	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ITPR1—breast cancer	3.79e-05	0.000334	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ALB—breast cancer	3.76e-05	0.000332	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—RAF1—breast cancer	3.67e-05	0.000324	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ABCB1—breast cancer	3.64e-05	0.000322	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.63e-05	0.000321	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NOS3—breast cancer	3.6e-05	0.000318	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—TYMS—breast cancer	3.58e-05	0.000316	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—RAF1—breast cancer	3.55e-05	0.000313	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOR1—breast cancer	3.54e-05	0.000312	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTM1—breast cancer	3.54e-05	0.000312	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PLA2G4A—breast cancer	3.54e-05	0.000312	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CG—breast cancer	3.46e-05	0.000306	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GPX1—breast cancer	3.39e-05	0.000299	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP1A1—breast cancer	3.35e-05	0.000296	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ERCC2—breast cancer	3.32e-05	0.000293	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CB—breast cancer	3.32e-05	0.000293	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SRC—breast cancer	3.32e-05	0.000293	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PTGS2—breast cancer	3.29e-05	0.00029	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—VEGFA—breast cancer	3.23e-05	0.000285	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—MTHFR—breast cancer	3.12e-05	0.000276	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—MAPK3—breast cancer	3.06e-05	0.00027	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CD—breast cancer	3.05e-05	0.000269	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ALB—breast cancer	3.01e-05	0.000265	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—TGFB1—breast cancer	2.97e-05	0.000262	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CAV1—breast cancer	2.88e-05	0.000254	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NOS3—breast cancer	2.88e-05	0.000254	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PTEN—breast cancer	2.87e-05	0.000253	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.75e-05	0.000243	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—KRAS—breast cancer	2.75e-05	0.000243	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CB—breast cancer	2.65e-05	0.000234	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PTGS2—breast cancer	2.63e-05	0.000232	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CG—breast cancer	2.63e-05	0.000232	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CA—breast cancer	2.52e-05	0.000223	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—TP53—breast cancer	2.44e-05	0.000216	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—HRAS—breast cancer	2.34e-05	0.000206	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CD—breast cancer	2.31e-05	0.000204	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PTEN—breast cancer	2.29e-05	0.000202	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ALB—breast cancer	2.28e-05	0.000201	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NOS3—breast cancer	2.18e-05	0.000192	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—AKT1—breast cancer	2.06e-05	0.000182	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CA—breast cancer	2.02e-05	0.000179	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CB—breast cancer	2.01e-05	0.000178	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PTGS2—breast cancer	1.99e-05	0.000176	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PTEN—breast cancer	1.74e-05	0.000153	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—AKT1—breast cancer	1.65e-05	0.000146	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CA—breast cancer	1.62e-05	0.000143	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—AKT1—breast cancer	1.32e-05	0.000117	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CA—breast cancer	1.23e-05	0.000108	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—AKT1—breast cancer	1e-05	8.84e-05	CbGpPWpGaD
